share_log

Janux Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

SEC ·  Jul 17, 2023 08:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more